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Objective: To evaluate the perioperative (30-day) and long-term outcomes of carotid endarterectomy (CEA) in elderly
patients with severe symptomatic and asymptomatic carotid disease. Although the efficacy of CEA in preventing
stroke in selected patients has been clearly demonstrated, concern has been expressed about the role of CEA in people
over 80 years old.
Methods: An analysis was conducted on a prospectively compiled computerized database of all primary CEAs performed at
our institution from 1990 to 2007. Descriptive demographic data, risk factors, surgical details, perioperative strokes and
deaths, and other complications were recorded. All patients underwent postoperative duplex ultrasound scanning and
clinical follow-up at one, six, and 12months, and yearly thereafter. Survival analyses were performed using Kaplan-Meier
life-tables. Long-term relative survival after CEA was assessed against age- and gender-matched controls.
Results: In all, 1769 CEAs were performed in 1562 patients, 193 of them (207 CEAs; group I) were > 80 years old and
1371 were younger (1562 CEAs; group II). All CEA procedures were performed with patients under deep general
anesthesia with continuous perioperative EEGmonitoring for selective shunting. No strokes or deaths occurred in group
I, whereas there were 11 perioperative strokes and three deaths in group II (1%). A complete follow-up (median, 5.2
years) was obtained in 185 elderly patients: no late occlusions or restenoses were detected, while the seven-year freedom
from stroke and death were 96.6% and 52.4%, respectively. The relative seven-year survival rate was 99.8%.
Conclusions: CEA in elderly patients proved safe and effective, with an excellent long-term durability. The long-term
relative survival after CEA in elderly patients was better than in an age-and gender-matched population, so the likelihood
of living long enough to benefit from CEA is not jeopardized by being very elderly. ( J Vasc Surg 2009;50:518-25.)The current demographic trend throughout the indus-
trialized world is for a longer life expectancy and a conse-
quently aging population. In Italy, an 80-year-old female
now has a mean life expectancy of 9.6 years and a male 7.7
years, and an 85-year-old female has a mean life expectancy
of 6.6 years and a male 5.4 years.1 The Eurostat 2008-
based national population projections (the EUROPOP
2008, convergence scenario) show that the proportion of
people aged 65 or more in the total EU27 population is
predicted to increase from 17.1% in 2008 to 30.0% in 2060,
and the figure is expected to rise from 84.6 million in 2008
to 151.5million in 2060. The number of people aged 80 or
more is likely to almost triple, from 21.8 million in 2008 to
61.4 million in 2060,2 with fewer and fewer young people
supporting an increasing proportion of elderly people.
Since the incidence of stroke and stroke-related mor-
tality is known to increase dramatically with advancing
age,3 even if the incidence of stroke is to remain stable, a
marked increase in the number of strokes can be expected
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518simply because of these demographic trends. As a growing
proportion of the population lives longer and the incidence
of cerebrovascular events is higher in the elderly, prevent-
ing stroke will be a tremendous challenge for societies and
health systems.
Large randomized controlled trials (RCTs) have shown
that carotid endarterectomy (CEA) is superior to medical
therapy in the prevention of stroke in symptomatic patients
with severe (70%) carotid stenosis4,5 and, to a lesser
extent, in those with asymptomatic carotid disease.6,7 For
CEA to be worthwhile, however, the long-term benefit
(preventing stroke) must outweigh the perioperative risk
(stroke and death). Although the perioperative stroke and
mortality rates after CEA recorded in the RCTs are still
considered acceptable, they are now 15-20 years old and
the current literature has demonstrated that they have
dropped drastically over time, while medical treatments
have improved considerably since the RCTs were con-
ducted. An aggressive stroke risk factor management and
appropriate treatment of carotid lesions can therefore sig-
nificantly improve not just the longevity but also the useful
life expectancy of elderly people.
Despite the above-mentioned epidemiological fore-
casts and the effective and beneficial results of an aggressive
treatment, concern remains about the role of CEA in
patients over 80, based on the inherent risks of the surgical
procedure and the uncertainty surrounding the long-term
survival of this population after CEA, so a different proce-
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ommended as an alternative treatment option.8-11 We an-
alyzed the perioperative (30-day) stroke and death rates,
the incidence of late occlusions and recurrent stenoses, and
the long-term and stroke-free survival rates after CEA in
patients aged 80 years or more with severe symptomatic
and asymptomatic carotid disease.
PATIENTS AND METHODS
Demographic and clinical data were prospectively en-
tered into a computerized vascular surgery registry for all
patients who underwent CEA for severe symptomatic and
asymptomatic internal carotid artery (ICA) disease, accord-
ing to the recommendations of the North American Symp-
tomatic Carotid Endarterectomy Trial (NASCET)4 and the
Asymptomatic Carotid Atherosclerosis Study (ACAS),6 at
our institution over an 18-year period (1990-2007). For
the purposes of this study, the registry was queried to
identify patients aged 80 or more (group I) and under 80
years old (group II) who underwent CEA. Patients sched-
uled for CEA with concomitant coronary artery bypass
grafting, or with associated supra-aortic trunk lesions re-
quiring concurrent surgery, and patients requiring proce-
dures for recurrent disease were ruled out. The patients’
demographic and clinical data were recorded on a standard-
ized form, including potential risk factors for atherosclero-
sis, anatomical and clinical variables, details of surgery, and
all complications. The diagnosis of an ICA lesion was based
on preoperative digital subtraction angiography (DSA)
during the earlier part of this study (used with decreasing
frequency over the years), while duplex ultrasound (US) scan
was the only preoperative carotid imaging study performed in
most patients frommid-1998 onwards, combined in selected
patients (those who either had a pseudo-occlusion on duplex
US scan or a stenosis of the ICA intracranial segment detected
by transcranialDoppler sonography)withmagnetic resonance
angiography (MRA), computed tomography angiography
(CTA), or DSA. The velocity criteria, as described else-
where,12 not the features of the plaque, were taken into
account for CEA decision. A neurological evaluation was
performed in all patients by the consultant neurologist
preoperatively, at the awakening from the anesthesia, at the
dismissal from the hospital, and during the follow-up. All
patients were on antiplatelet therapy: aspirin 100 mg daily
or ticlopidine 500 mg daily and, in the recent years, clopi-
dogrel 75 mg daily. All patients with diabetes, hyperlipid-
emia, and/or hypoechoic plaques were on statin therapy.
Preoperative patient preparation was standardized.
All CEA procedures involved either traditional CEA
with patch (n  302; the only patch material used was
polytetrafluoroethylene [PTFE, Gore-tex, WL Gore, Elk-
ton, MD]) in the first period of the study, or eversion CEA
later on (n  1467). The technical details of both proce-
dures have been described elsewhere.13,14 All CEA were
performed by the same surgeon with patients under deep
general anesthesia and continuous perioperative electroen-
cephalographic (EEG) monitoring for selective shunting.
Shunting criteria were based exclusively on EEG changesconsistent with cerebral ischemia. No completion imaging
studies were performed. None of the CEA procedures
considered in this series were aborted or incomplete, and
none of the patients were refused CEA for technical reasons
emerging during surgery.
Patients were usually monitored in the recovery room
for two hours until their blood pressure and neurological
status were considered acceptable, then they were trans-
ferred to a nursing unit specializing in vascular care and
monitored for the next 12-24 hours after surgery. All
patients with severe headache were observed for hyperper-
fusion syndrome, and hypertension was treated aggres-
sively. Most patients were discharged 48-72 hours after
CEA.
Surveillance protocol. After discharge, visiting nurses
monitored the patients’ blood pressure and neurological
status. All surviving patients systematically underwent
physical and neurological assessment by a consultant neu-
rologist, and concomitant duplex US scan performed by
two experienced technologists one, six, and 12 months,
then yearly, after surgery, assessing any occlusion or recur-
rent carotid disease. A peak systolic velocity (PSV) of more
than 140 cm/s with spectral broadening throughout sys-
tole and an increased peak diastolic velocity were consistent
with a stenosis  50% diameter reduction and a PSV of
more than 210 cm/s with an end diastolic velocity between
110 and 140 cm/s were consistent with  70% stenosis.
Neurological events were always classified by the consultant
neurologist as transient ischemic attack (TIA; ie, temporary
hemispheric symptoms lasting nomore than 24 hours, with
complete recovery), amaurosis fugax (transient monocular
visual loss), or stroke (minor: a clinical syndrome of rapidly
developing signs or symptoms of focal loss of cerebral
function of vascular origin, lasting more than 24 hours and
not leading to any handicap or significant impairment in
activities of daily living [modified Rankin-scale15 (mRS) 
3] or major: a focal neurological deficit lasting more than
30 days and inducing a change in lifestyle [mRS 3/5]).
Brain imaging (computed tomography [CT] or magnetic
resonance imaging [MRI]) was performed in all patients
presenting a new neurological deficit after CEA. Cardiac
complications were classified by a single cardiologist and
included: 1) myocardial infarction (MI) with a diagnosis
based on creatinine kinase-MB levels and electrocardio-
gram (ECG) findings; 2) pulmonary edema confirmed by
chest X-ray; 3) documented ventricular fibrillation or pri-
mary cardiac arrest; and 4) new complete heart failure
(CHF), requiring a pacemaker. A postoperative ECG was
routinely obtained in all patients who had a history of
coronary artery disease, CHF, or arrhythmia (rhythm other
than sinus) and cardiac isoenzymes were obtained in all
patients who had new findings at postoperative ECG.
Other complications and events observed during follow-up
were recorded in accordance with the guidelines of the Ad
Hoc Committee on Reporting Standards for Cerebrovas-
cular Disease, Society for Vascular Surgery/North Ameri-
can Chapter of the International Society of Cardiovascular
Surgery.16
teral c
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death, carotid restenoses or late occlusions, and long-term
and stroke-free survival in groups I and II.
Statistical analysis. All values are expressed as mean 
SD. Continuous data were compared with the Student’s t
test (two-tailed) and categorical variables with Pearson’s 2
test (two-tailed) or Fisher’s exact test, as appropriate, cal-
culating the odds ratio (OR) with 95% confidence intervals
(CIs). Cumulative life-table analyses (Kaplan-Meier) were
used to assess long-term and stroke-free survival rates.
Curves were compared with the log-rank test. The relative
survival is the ratio of the survival observed in patients to the
expected survival of the general Italian population matched
for age, gender, and calendar time.1 Relative survival analysis
was done with a SAS macro (SAS version 8.2; SAS Institute
Inc, Cary, NC) based on the Hakulinen method.17 Statistical
significance was inferred for P  .05. Several data items
were analyzed vis-à-vis surgical procedures rather than pa-
tients because each perioperative and long-term outcome
was correlated with the surgical procedure, and because
patients who underwent bilateral CEAs were exposed to
twice the risk of stroke, death or carotid restenosis or
occlusion.
RESULTS
Overall, 1769 CEA procedures were performed in
1564 patients, 193 of them aged  80 years (group I,
12.3%), while the other 1371 (group II, 87.7%) were
younger. Two-hundred and five patients underwent staged
bilateral CEAs (14 in group I and 191 in group II, respec-
tively). In group I, the number of CEAs progressively
increased over time, from the initial 42 in 1990-1995 to 68
in 1996-2001 and then 97 in 2002-2007. The preoperative
baseline characteristics of the two groups are summarized
Table I. Baseline characteristics
Group I (n  193) Group II
CEA procedures, n (%) 207 (11.7) 1562
Mean age, yrs (range) 84.8 (80-96) 68.6
Male, n (%) 139 (72.0) 963
Risk factors
Hypertension, n (%) 129 (66.8) 796
Smoking, n (%) 143 (74.1) 929
Diabetes, n (%) 47 (24.3) 451
Hyperlipidemia, n (%) 77 (39.9) 621
Cardiac disease, n (%) 96 (49.7) 603
CKD, n (%) 16 (8.3) 101
Pulmonary disease, n (%) 31 (16.0) 213
Symptomatic, n (%) 155 (74.9) 971
TIA, n (%) 73 (35.3) 464
Amaurosis fugax, n (%) 29 (14.0) 211
Stroke, n (%) 53 (25.6) 296
Asymptomatic, n (%) 52 (25.1) 591
Contralateral CO, n (%) 82 (42.5) 167
CEA with patching, n (%) 35 (16.9) 267
Eversion CEA, n (%) 172 (83.1) 1295
Shunting, n (%) 63 (30.4) 238
CEA, Carotid endarterectomy; CKD, chronic kidney disease; CO, contralain the Table I. More than 70% of the patients were males, inboth groups. The mean age was 84.8 years (range, 80-96
years) in the older group and 68.6 years (range, 31-79
years) in the younger group. The incidence of arterial
hypertension was statistically higher in the older group
(66.7% vs 58.0%, P  .020), while the younger patients
were significantly more likely to have diabetes mellitus
(32.1% vs 24.3%, P  .017). Although there were more
smokers among the very elderly (74.1% vs 67.8%), the
difference failed to reach statistical significance (P .076).
There was also no statistically significant difference between
the two groups in terms of the incidence of hyperlipidemia
or cardiac, pulmonary or chronic kidney diseases. Symp-
tomatic lesions were more frequent in group I (74.9% vs
62.1%, P  .001), with a statistically higher frequency of
patients with stroke (P  .026). The type of CEA proce-
dure used (traditional with patching or eversion) was much
the same in the two groups, but eversion CEA was per-
formed more often than traditional CEA, both in the series
as a whole (P .001) and in each group (83.1% vs 16.9% in
the older group, P  .001; and 82.9% vs 17.1% in the
younger group, P .001). Among the older patients, there
was a significantly higher prevalence of contralateral ICA
occlusion (P .001) and use of intraluminal shunting (P
.001) (Table I).
Perioperative mortality and stroke rates. Overall,
the perioperative mortality and stroke rates were 0.16% and
0.62% (11 of 1769), respectively, with a combined mortal-
ity and stroke rate of 0.79% (Table II). No significant
differences emerged between the two groups in terms of
perioperative neurological events or deaths. Perioperative
death and stroke only occurred in the younger group.
There were three perioperative deaths; two were due to an
MI, and one to a fatal stroke. All the other strokes (six
CEAs with patching and four eversion CEAs) occurred in
1371) Total (n  1564) OR (95% CI) P value
3) 1769 (100)
79)
2) 1102 (70.5) .612
0) 925 (59.1) 1.45 (1.06-2.00) .020
8) 1072 (68.5) 0.73 (0.52-1.03) .076
9) 498 (31.8) 0.66 (0.46-0.93) .017
3) 698 (44.6) 0.80 (0.59-1.09) .158
0) 699 (44.7) 1.26 (0.93-1.70) .132
) 117 (7.5) 1.13 (0.66-1.96) .648
5) 244 (15.6) 1.04 (0.69-1.56) .850
1) 1126 (63.6) 1.81 (1.30-2.52) .001
7) 537 (30.3) 1.29 (0.95-1.75) .102
5) 240 (13.6) 1.04 (0.69-1.58) .843
9) 349 (19.7) 1.47 (1.05-2.06) .026
8) 643 (36.4) 1.81 (1.30-2.52) .001
2) 249 (15.9) 5.32 (3.84-7.38) .001
1) 302 (17.1) 0.98 (0.67-1.45) .947
9) 1467 (82.9) 0.98 (0.67-1.45) .947
2) 301 (17.0) 2.43 (1.75-3.37) .001
arotid occlusion; TIA, transient ischemic attack.(n 
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surgery, while the patient was still in the recovery room:
duplex US scan immediately confirmed ICA occlusion in
the patched arteries, and ICA patency in the everted arter-
ies. Four of the patched patients underwent redo-surgery
consisting of thrombectomy and a new patch-plasty: only
one patient had some improvement in neurological status.
The other two strokes involved the hemisphere contralat-
eral to the operated side (one of these was ipsilateral to an
occluded ICA). Among the four strokes in everted patients,
two were major and two minor. Both major strokes oc-
curred in patients (one of them was shunted) with a mildly
diseased contralateral ICA and produced, based on cerebral
CT scans, a cortical infarction in the territory of the middle
cerebral artery: since they could not possibly be due to
technical errors, we assumed they were embolic (from the
aortic arch or the heart). Both minor strokes were most
likely hemodynamic in nature, since they were border zone
infarcts, judging from the CT images: one developed in the
hemisphere contralateral to the revascularized ICA and
ipsilateral to an occluded ICA.
Minor perioperative neurological events. Fifty-eight
(3.3%) perioperative TIAs were observed and more than
half of them (32 of 58, 55.2%) occurred in the middle
cerebral artery territory contralateral to the operated side.
In all cases, duplex US scan performed immediately after
the onset of neurological signs showed that the revascu-
larized ICA was patent and cerebral CT or MR images
were negative for any new ischemic events. The differ-
ence between the two groups was not statistically signif-
icant (Table II).
Other complications. Overall, there were 16 periop-
Table II. Perioperative (30-day) results
Group I
(193 pts, 207 CEAs) (1371
Stroke, n (%) 0
Major
Ipsilateral
Contralateral
Minor
Ipsilateral
Contralateral
Death, n (%) 0
Stroke-related
Combined stroke and death, n (%) 0
TIA, n (%) 11 (5.3)
Ipsilateral 4
Contralateral 7
Combined stroke and TIA, n (%) 11 (5.3)
Cardiac complications, n (%) 2 (0.96)
MI 0
Fatal
Non-fatal
CHF 1
Arrhythmia 1
Neck hematoma, n (%) 12 (5.8)
Nerve injury, n (%) 7 (3.4)
CEA, Carotid endarterectomy; CHF, congestive heart failure; MI, myocarderative cardiac complications (0.9%). Only two were fatal(MI) and occurred in two symptomatic patients in group
II. The incidence of cardiac complications did not differ
statistically between the older and younger groups (Table
II). No hyperperfusion syndrome was seen in any of the
patients. Overall, there were 97 (5.5%) neck hematomas
requiring surgical evacuation, with no further complica-
tions; the suture line was intact in all cases, and venous
oozing from the superficial layers was the only apparent
source of bleeding. No statistically significant difference
emerged between the groups (Table II).
Other surgical morbidities included 79 nerve injuries
(4.5%), with 66 (3.7%) involving the cranial nerves and 13
(0.7%) the cervical nerves. The hypoglossal nerve was in-
volved 41 times, the recurrent laryngeal nerve 12 times, the
superior laryngeal nerve eight times, the marginal mandib-
ular nerve five times, the greater auricular nerve 10 times,
and the transverse cervical nerve three times. All nerve
dysfunctions were transient, and all but four recurrent
laryngeal nerve injuries regressed completely within six
months of the CEA; two patients took 12 months to
recover and two did not recover until 31 and 37 months
later. There was no statistically significant difference be-
tween the groups (Table II).
Long-term results. After excluding the three periop-
erative deaths, 1561 patients were alive 30 days after CEA,
but 57 (3.6%) were lost to follow-up. A complete follow-up
was therefore obtained in 1504 patients (1699 CEAs), 185
of them (198 CEAs) in the older group (Table III).
In group I, the median follow-up was 5.2 years (mean, 7
2.5years; range,0.1-18years); ingroupII, themedian follow-up
was 8.6 years (mean, 9 4.5 years; range, 0.1-18 years).
Overall, 8 ICA occlusions were detected (0.4%; in six
up II
562 CEAs) OR (95% CI) P value
Total
(1564 pts, 1769 CEAs)
0.70) 0 (0.0-2.62) .628 11 (0.62)
9
7
2
2
1
1
0.19) 0 (0.0-9.69) .688 3 (0.16)
1
0.89) 0 (0.0-2.06) .394 14 (0.79)
3.0) 1.81 (0.93-3.51) .080 58 (3.3)
2
5
4.2) 1.45 (0.76-2.79) .264 69 (3.9)
0.89) 1.08 (0.27-4.29) .710 16 (0.90)
3 3
2
1
8 9
3 4
5.4) 1.07 (0.58-1.98) .833 97 (5.5)
4.6) 0.72 (0.33-1.57) .422 79 (4.5)
arction; TIA, transient ischemic attack.Gro
pts, 1
11 (
3 (
14 (
47 (
2
2
58 (
14 (
85 (
72 (patched and two everted arteries), and they were all in
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not shunted and occurred without symptoms within the
first postoperative year, all in arteries patent at the first two
duplex US scans.
There were 19 (1.1%) restenoses  50% altogether,
three of which were detected in group I and involved ICAs
that were not shunted (14 were patched), and they oc-
curred without symptoms within 24 months of surgery. Of
these 19 restenoses, 9 (0.6%, all in group II) were  70%,
giving a combined occlusion/restenoses  70% rate of
1.0% (Table II). All but two remained stable at subsequent
duplex US scans and were treated conservatively. In these
two arteries (one patched), the restenosis  70% pro-
gressed rapidly and became severe enough ( 90%) to
demand a second CEA or a CAS procedure respectively 19
and 22 months after the first revascularization.
Overall, there were 14 late strokes (0.8%), three of
them in group I (1.6%): four were cardioembolic, eight
lacunar (two in group I, both contralateral to the operated
side) and two (one in group I, ipsilateral to the operated
side, and contralateral to an ICA occlusion) were probably
hemodynamic in nature, judging from the CT images.
Kaplan-Meier analysis showed that the freedom from
strokes at one, three, five, and seven years was 100%, 99.4 
0.6%, 96.6  2.4%, and 96.6  2.3% in group I and 99.9 
0.1%, 99.6 0.2% , 99.1 0.3%, and 99.0 0.3% in group
II, (OR 2.86; 95% CI, 0.78-33.08; P .088) (Fig 1).
One hundred and five late deaths occurred in the series
as a whole, two of which (both in group II) were stroke-
related (a fatal stroke in a patient with an atrial fibrillation of
recent onset, and another fatal stroke contralateral to the
revascularized side and ipsilateral to an ICA occlusion). The
cause of late death was primarily cardiac-related (n  48)
(Table IV). The observed survival at one, three, five, and seven
years was 99.5  0.5%, 95  2%, 74.3  5.4%, and 52.4 
9.3% in group I and 99.8  0.1%, 97.5  0.5%, 94  0.7%,
and 88.2  0.9% in group II (OR  4.30; 95% CI 8.35-
34.42; P  .001) (Fig 2). The five- and seven-year relative
survival rates of the elderly patients were 112.5% and
Table III. Long-term results
Group I
(185 pts, 198 CEAs) (1319 p
Stroke, n (%) 3 (1.6)
Ipsilateral 1
Contralateral 2
Death, n (%) 31 (16.7)
Stroke-related 0
Restenoses  50%, n (%) 3 (1.5)
Restenoses  70%, n (%) 0
ICA occlusion, n (%) 0
Restenoses  70% plus occlusions,
n (%)
0
CEA, Carotid endarterectomy; ICA, internal carotid artery.
*by Fisher exact test.99.8%, respectively (Fig 3).DISCUSSION
The results of this study show that CEA is safe and
Fig 1. Kaplan-Meier curves show the freedom from stroke of the
two groups who underwent carotid endarterectomy.
p II
01 CEAs) OR (95% CIs) P value
Total
(1504 pts, 1699 CEAs)
.8) 1.96 (0.58-6.60) .400* 14 (0.8)
2.38 (0.34-16.75) .409* 4 (0.2)
1.79 (0.42-7.52) .354* 10 (0.6)
.6) 3.38 (2.16-5.30) .001 105 (6.7)
0 (0.0-13.75) .769* 2
.1) 1.43 (0.44-4.63) .478* 19 (1.1)
.6) 0 (0.0-3.23) .610* 9 (0.5)
.5) 0 (0.0-3.64) .607* 8 (0.4)
.1) 0 (0.0-1.70) .247* 17 (1.0)
Table IV. Causes of late deaths
Cause
Group I,
185 pts n (%)
Group II,
1319 pts n (%)
Total, 105
deaths n (%)
Cardiac disease 17 (9.2) 31 (2.3) 48 (45.7)
AAA rupture 0 1 (0.07) 1 (1)
Stroke 0 2 (0.15) 2 (1.9)
Pancreatitis 2 (1.1) 2 (0.15) 4 (3.8)
Cancer 4 (2.2) 19 (1.4) 23 (21.9)
Renal failure 2 (1.1) 5 (0.38) 7 (6.7)
Suicide 0 1 (0.07) 1 (1)
Car accident 1 (0.5) 6 (0.45) 7 (6.7)
Trauma 1 (0.5) 2 (0.15) 3 (2.9)
Unknown 4 (2.2) 5 (0.38) 9 (8.6)
Total 31 (16.7) 74 (5.6) 105 (100)
AAA, Abdominal aortic aneurysm.Grou
ts, 15
11 (0
3
8
74 (5
2
16 (1
9 (0
8 (0
17 (1effective in patients with severe symptomatic and asymp-
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rate of less than 1%, and that CEA can be performed in
patients  80 years old with perioperative stroke risk and
death rates comparable with those of younger patients, as
reported in many other institutional series18-31 (Table V).
Moreover, these findings correlate well with, and expand
on the results of our two previous, smaller studies on early
outcomes in this patient population.32,33
Despite evidence that the incidence of stroke increases
with age, that the outcome of the best medical therapy is
worse in the elderly, and that perioperative surgical treat-
ment is safe and effective in octogenarians, many clinicians
Fig 2. Kaplan-Meier curves show the long-term cumulative sur-
vival of the two groups. Standard error exceeds 10% in group I after
seven years.
Fig 3. The long-term relative survival of the elderly patients who
underwent carotid endarterectomy. Standard error exceeds 10% in
group I after seven years. The survival of age- and gender-matched
Italian population was plotted for reference.still doubt the overall benefit of CEA in such patients, giventheir higher risk of complications due to associated comor-
bidities and their limited life expectancy. This concern has
significantly curtailed the referral of elderly patients for
CEA, prompting many of them to accept the option of a
seemingly lower-risk and less invasive treatment, such as
CAS. The conviction that CAS is preferable to CEA in the
very elderly appears to be based on two premises that
remain to be seen (ie, that CEA is a high risk procedure and
that CAS is safer than CEA). The first premise is not
supported by the perioperative outcomes emerging from
our own and many other institutional studies, which have
failed to reveal any relationship between old age and peri-
operative adverse events in the performance of CEA, re-
porting excellent results in such patients and demonstrating
that the very elderly could even benefit from CEA more
than their younger counterparts.18-31 The second premise
is belied by the analysis of the periprocedural results of
many observational series,8-11 and recent data from the
lead-in phase of CREST study (a 30-day death/stroke rate
of 12.1%),34 the CAPTURE 3500 study (30-day death/
stroke/MI rates of 17.1% and 8% in symptomatic and
asymptomatic elderly people, respectively),35 and the
CASES PMS study (a 30-day death/stroke/MI rate of
7.3%),36 which revealed that the periprocedural risk of
stroke and death increases with age, causing an unaccept-
able risk for the very elderly. The conclusion one may draw
from all these studies is that octogenarians should be con-
sidered high-risk patients for CAS procedures and the
common practice of recommending CAS for older patients
is questionable and should be abandoned until the results
of RCTs demonstrate that CAS under protection could
give results at least no worse than CEA in this subgroup of
the population.
Because the incidence of late occlusions and restenoses
after CEA can be interpreted as a measure of the durability
of the surgical treatment, the lack of occlusions or severe
restenoses in our elderly patients over a mean follow-up of
7  2.5 years, and an overall combined occlusion and
severe restenosis rate of 1.0% in 1699 CEAs performed in
1504 patients consequently demonstrate that CEA is a
durable procedure. Surprisingly, no occlusions stemmed
from any progression of restenosis, since the endarterecto-
mized vessel was normal on the previous duplex US scan;
occlusions and restenoses developed more often in patched
than in everted arteries (20/27 cases, 74%). Although
recurrent carotid stenosis remains a conundrum because
reports vary widely on its incidence and differ in the dura-
tion of follow-up, the criteria used to determine and define
the restenosis, and the method used to close the arteriot-
omy, our finding is consistent with reports from other
authors of a lower ICA restenosis rate after eversion than
after CEA with patching or primary closure.37
The cumulative seven-year survival of our elderly pop-
ulation was 52.4%, a figure comparable with those reported
by many authors.19,21-24,26,29,30,38 However, when back-
ground all-cause mortality is taken in account, the long-
term relative survival of our elderly patients after CEA was
greater than in the age- and gender-matched Italian popu-
JOURNAL OF VASCULAR SURGERY
September 2009524 Ballotta et allation. The finding that octogenarians CEA patients lived
longer than the average  80-year-old is not new. In a
population-based study on all patients who underwent
CEA for a 10-year period in Western Australia, Norman
et al38 calculated a relative five-year survival of 118% (95%
CIs: 102-134) in 151 patients  80 years of age, attribut-
ing this excellent survival to a careful patient selection.
Similarly, Schneider et al reported that the 81% four-year
survival recorded in their 90 octogenarian patients who
underwent CEA was comparable with, if not better, than
that of their age-matched peers. In the absence of any
RCTs, it is very hard to say whether CEA increases life
expectancy in elderly patients. Although the causes of four
late deaths (2.2%) were undetermined, and therefore some
may have been stroke-related, no late stroke-related deaths
occurred in our elderly population, so CEA does not seem
to afford a prolonged survival advantage. The only late
ipsilateral ischemic stroke, probably due to cerebral hemo-
dynamics, and the two other lacunar strokes, contralateral
to the operated side, would support the efficacy of CEA in
preventing late strokes related to carotid disease, but would
suggest that CEA cannot prevent all late strokes. The
seven-year rate of freedom from stroke of 96.6% nonethe-
less indicates that most of our octogenarians lived the rest
of their lives without stroke.
This study has some limitations. Although the data
were collected prospectively, the analysis was retrospective
in nature. There may be a selection bias because healthier
patients may have been referred for CEA, although we
cannot infer this from the available data and we do not
believe this is the case. The elderly patients were signifi-
cantly less likely than their younger counterparts to have a
history of diabetes, but it is just a reflection of the general
population in that people with diabetes and carotid disease
are less likely to survive into their 80s. Octogenarians had
symptoms significantly more often than the younger pa-
Table V. Reported perioperative outcomes of CEA proce
Author
Patients  8
CEA, n Stroke an
Schultz18 116
Pinkerton and Golkar19 125
Treiman20 183
Coyle21 79
O’Hara22 182
Perler23 1036 2
Ting24 59
Maxwell25 218
Schneider26 90
Oszvath27 125
Rockman28 161
Pruner29 345
Miller30 360 1
Stoner31 1341 6
Present series 207
CEA, Carotid endarterectomy.tients, and a significantly higher incidence of prior stroke.The statistically greater presence of contralateral ICA oc-
clusions in the very elderly might explain the significantly
more frequent need for shunting, but this did not appear to
negatively influence perioperative outcome. In addition,
despite a high incidence of preoperative cardiac disorders
(49.7%), only two patients (1%) experienced early cardiac
complications, neither of which proved fatal and both were
managed with ease. Finally, although this report concerns a
large group of CEA procedures performed in patients 80
years of age, the size of the sample is still small, and the
number of perioperative adverse events was nil, so the
relative lack of power makes any definitive statistical analysis
impossible.
In conclusion, CEA in patients  80 years of age is a
safe and effective procedure with an excellent long-term
durability. This should be the standard against which alter-
native treatments are judged. Although CEA cannot pre-
vent all late strokes, most of our octogenarians lived the rest
of their lives without any stroke. The long-term relative
survival after CEA performed in patients  80 years of age
is better than the survival of an age- and gender-matched
population, so the likelihood of living long enough to
benefit from a CEA is not jeopardized by the fact of being
very elderly.
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